Cross-priming underlies the efficacy of antibody–drug conjugates and immunotherapy combinations

Trends in Immunology · Published 2026-06-01 · DOI 10.1016/j.it.2026.06.003

Authors (5)

Gabriel Gomis, Pedro Berraondo, Claudia Herrero, Carlos Luri-Rey, Ignacio Melero

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Gomis, G., Berraondo, P., Herrero, C., et al. (2026). Cross-priming underlies the efficacy of antibody–drug conjugates and immunotherapy combinations. Trends in Immunology. https://doi.org/10.1016/j.it.2026.06.003

Related articles